Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
Manute Bol, 47, has died. The 7-foot-7 former NBA star died Saturday at the University of Virginia Medical Center in Charlottesville, where he was being treated for acute kidney failure and Stevens Johnson Syndrome (SJS), a serious skin disorder caused by an allergic reaction to medication.
Telaprevir, a new treatment for hepatitis C by Vertex Pharmaceuticals, is showing positive results from a late-stage study, boosting company shares. But TheStreet.com warns that despite the promising results, the treatment has issues that may be making investors cautious, including a link to the serious allergic reaction Stevens Johnson Syndrome (SJS).
When he was not quite 2 years old, James Lumasag was diagnosed with a rare but life threatening skin condition after receiving a round of antibiotics to treat a cough and fever. The toddler fought for his life in the intensive care unit of a hospital, where he received 22 bags of plasma as his skin peeled away from his body. “His whole body, except his head, looked totally burnt,” his mother Merlyn said. “James suffered too much.”
You’ve likely seen the commercials for Detrol. A woman is sitting in her doctor’s office and a woman-shaped figure similar to the ones seen on bathroom doors, is encouraging her to talk to her doctor about her frequent and sudden urges to go to the bathroom. The treatment has helped women find relief from overactive bladder.
The Food and Drug Administration (FDA) in partnership with OSI Pharmaceuticals Inc., and Genentech have issued a warning letter to healthcare professionals informing them of new safety information added to the WARNINGS AND PRECAUTIONS section of the cancer treatment drug Tarceva.
The new information, gathered from a clinical study and postmarketing reports, revealed sometimes fatal incidences of gastrointestinal perforation, bullous, blistering and exfoliative skin conditions including cases suggestive of Stevens Johnson Syndrome (SJS) and/or toxic epidermal necrolysis (TEN) and ocular disorders including corneal perforation or ulceration.
Seven major pharmaceutical companies are banding together to develop genetic tests that predict which patients will have adverse side effects from drugs. The group, a nonprofit organization dubbed the International Serious Adverse Events Consortium (SAEC), will conduct two studies, one to look at drug-related liver toxicity and the other aimed at a rare drug-related skin condition called Stevens-Johnson syndrome.
![[ Beasley Allen Law Firm Logo ]](http://www.sjs-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}